# Clinical trials recruiting in India: 765 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 765 trials recruiting or not yet recruiting with a site in India, as read on November 19, 2026.

## The full list

Clinical trials recruiting in India: 765 rows for $38.25, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 24 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/country/india

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 765
- Recruiting or not yet: 765
- Read on: November 19, 2026

## Trials

The 25 newest of 765, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07947056 | A Clinical Trial to Improve Treatment Outcomes Among Persons With Drug Sensitive Pulmonary TB Treated With 4 or 6 Months of High Dose... | Tuberculosis Research Centre, India | Phase 3 | Recruiting | Tuberculosis, Pulmonary, Drug Sensitive | 2,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07947056) |
| November 18, 2026 | NCT07944378 | A Study Evaluating the Safety and Effectiveness of Lokelma in Indian Patients With Hyperkalaemia | AstraZeneca | Phase 4 | Recruiting | Hyperkalemia | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944378) |
| November 17, 2026 | NCT07941973 | Effectiveness of Part Time vs Full Time Wear Protocols of Twin Block Appliance on Cephalometric Dental and Skeletal Changes | Postgraduate Institute of Dental Sciences Rohtak | Not applicable | Recruiting | Angles Class II Div 1 | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07941973) |
| November 16, 2026 | NCT07939347 | AVATAR Therapy for Distressing Voices in India and Ethiopia | King's College London | Not applicable | Not yet recruiting | Psychosis, Hallucinations | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939347) |
| November 12, 2026 | NCT07931547 | A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes, Chronic Kidney Disease | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931547) |
| November 6, 2026 | NCT07922330 | A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These... | AstraZeneca | Phase 3 | Not yet recruiting | Obesity, Overweight, Type 2 Diabetes Mellitus | 330 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922330) |
| October 30, 2026 | NCT07907250 | F-18 Sodium Fluoride PET/CT-Guided Pain Palliation in Chronic Plantar Fasciitis: A Comparative Study of ¹⁷⁷Lutetium-Corticosteroid-Local... | Post Graduate Institute of Medical Education and Research, Chandigarh | Not applicable | Recruiting | Plantar Fascitis, Chronic Heel Pain | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07907250) |
| October 30, 2026 | NCT07907120 | Cost-Effectiveness of Upfront Supplemental Anaesthesia in Symptomatic Irreversible Pulpitis | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Irreversible Pulpitis, Anesthesia, Local | 234 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07907120) |
| October 28, 2026 | NCT07902219 | Qurse Revand for MASLD: A Randomized Controlled Safety and Efficacy Trial | National Institute of Unani Medicine, Bengaluru | Phase 2 | Not yet recruiting | MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) | 128 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07902219) |
| October 28, 2026 | NCT07900633 | A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk | Eli Lilly and Company | Phase 3 | Not yet recruiting | Obesity, Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2 | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900633) |
| October 27, 2026 | NCT07899307 | Metformin in Acute Ischemic Stroke | All India Institute of Medical Sciences | Phase 3 | Not yet recruiting | Acute Ischemic Stroke | 440 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07899307) |
| October 27, 2026 | NCT07899125 | FLuorescent Angiography in REduction of Anastomotic Leak in Rectal Cancer Surgery | Basavatarakam Indo American Cancer Hospital & Research Institute | Not applicable | Not yet recruiting | Rectal Cancer Patients, Rectal Cancer Surgery, Colorectal Cancer, Anastomotic Leak Rectum, Anastomotic Leakage in Colon... | 610 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07899125) |
| October 23, 2026 | NCT07893002 | A Randomized, 52-Week Extension Study to Evaluate the Maintenance of Remission, Relapse Prevention, and Long-Term Safety of CreNeuroS™ in... | Sichuan Credit Pharmaceutical Co., Ltd. | Not applicable | Recruiting | Adjunct in the Treatment of Depressive Disorder | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07893002) |
| October 23, 2026 | NCT07891923 | Less Doses of Daratumumab Are Adequate to Achieve Response in Newly Diagnosed Multiple Myeloma | Tata Memorial Centre | Phase 2 | Recruiting | Newly Diagnosed Multiple Myeloma (NDMM) | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07891923) |
| October 21, 2026 | NCT07885891 | Cefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia | Wockhardt | Phase 3 | Not yet recruiting | Hospital Acquired Bacterial Pneumonia (HABP), Ventilator Associated Bacterial Pneumonia (VABP) | 324 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07885891) |
| October 21, 2026 | NCT07885592 | Neonatal Outcomes on Direct Fetal Intravenous Immunoglobulin During Intrauterine Transfusion for Rhesus Isoimmunization | Post Graduate Institute of Medical Education and Research, Chandigarh | Phase 2 | Recruiting | Hemolytic Disease of the Newborn, Fetal Anemia, Rhesus Isoimmunization, Erythroblastosis Fetalis Due to RH Antibodies | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07885592) |
| October 20, 2026 | NCT07883993 | Comparing AI and Standard Pregnancy Chatbots | Nivi, Inc. | Not applicable | Not yet recruiting | Pregnancy, Prenatal Care, Maternal Health | 2,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07883993) |
| October 19, 2026 | NCT07881432 | A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes | Eli Lilly and Company | Phase 3 | Not yet recruiting | Obesity | 2,115 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881432) |
| October 19, 2026 | NCT07880639 | Incidence of Post TIPS/DIPS Heart Failure and the Factors Associated With Post-TIPS/DIPS Heart Failure. | Institute of Liver and Biliary Sciences, India | Observational | Not yet recruiting | Liver Diseases | 127 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07880639) |
| October 14, 2026 | NCT07874139 | Prospective Study on Antimicrobial RESIstance in Chronic Pulmonary DiseasE | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Observational | Recruiting | Chronic Lung Diseases | 683 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07874139) |
| October 6, 2026 | NCT07861100 | A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Cardiovascular Risk, Obesity | 8,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07861100) |
| October 6, 2026 | NCT07859839 | Gabapentin vs. Benzonatate vs. Standard of Care for Cough in ILD | Post Graduate Institute of Medical Education and Research, Chandigarh | Phase 4 | Not yet recruiting | Interstitial Lung Disease | 177 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07859839) |
| October 2, 2026 | NCT07855913 | EUS-Guided Coil and Glue vs Glue Injection for Bleeding Gastric Varices in Cirrhosis | Medanta, The Medicity, India | Not applicable | Recruiting | Gastric Varices Bleeding, Cirrhosis | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07855913) |
| October 1, 2026 | NCT07851025 | Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced... | AstraZeneca | Phase 3 | Recruiting | Epithelial Ovarian Cancer | 950 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07851025) |
| September 28, 2026 | NCT07844109 | Glial Fibrillary Acidic Protein Testing and Handheld Near Infrared Spectroscopy Technology CEREBO in India. | Christian Medical College and Hospital, Ludhiana, India | Not applicable | Not yet recruiting | Stroke | 232 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07844109) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| All India Institute of Medical Sciences | New Delhi | 48 |
| Tata Memorial Hospital | Mumbai | 44 |
| Sir Ganga Ram Hospital | New Delhi | 25 |
| Institute of Liver & Biliary Sciences (ILBS) | New Delhi | 18 |
| All India Institute of Medical Sciences (AIIMS) | New Delhi | 17 |
| Asian Institute of Gastroenterology | Hyderabad | 16 |
| Tata Memorial Centre | Mumbai | 15 |
| Institute of Liver & Biliary Sciences | New Delhi | 12 |
| AIG Hospitals | Hyderabad | 12 |
| Lisie Hospital | Kochi | 11 |
| Institute of Liver and Biliary Sciences | New Delhi | 11 |
| KLES Dr. Prabhakar Kore Hospital & M.R.C | Belagavi | 10 |
| Amrita Institute of Medical Sciences | Kochi | 10 |
| Osmania General Hospital | Hyderabad | 9 |
| Christian Medical College Vellore | Vellore | 9 |
| Rajiv Gandhi Cancer Institute and Research Centre | New Delhi | 9 |
| Nirmal Hospital Pvt Ltd. | Surat | 9 |
| Government Medical College, Kozhikode | Kozhikode | 9 |
| Nil Ratan Sircar Medical College and Hospital | Kolkata | 9 |
| Deenanath Mangeshkar Hospital and Research Centre | Pune | 8 |
| Nizam's Institute of Medical Sciences | Hyderabad | 8 |
| Government Medical College | Kozhikode | 8 |
| Max Super Speciality Hospital | Patparganj | 8 |
| All India Institute of Medical Sciences (AIIMS) - Nagpur | Nagpur | 8 |
| Lifepoint Multispeciality Hospital | Pune | 8 |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 18 |
| Phase 1/2 | 7 |
| Phase 2 | 57 |
| Phase 2/3 | 23 |
| Phase 3 | 241 |
| Phase 4 | 36 |
| Not applicable | 242 |
| Observational | 141 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Diabetes Mellitus, Type 2 | 25 |
| Carcinoma, Non-Small-Cell Lung | 23 |
| Obesity | 21 |
| Renal Insufficiency, Chronic | 16 |
| Overweight | 16 |
| Uterine Cervical Neoplasms | 15 |
| Liver Cirrhosis | 15 |
| Breast Neoplasms | 15 |
| Heart Failure | 14 |
| Fibrosis | 12 |
| Head and Neck Neoplasms | 11 |
| Squamous Cell Carcinoma of Head and Neck | 11 |
| Cardiovascular Diseases | 10 |
| Schizophrenia | 10 |
| Neoplasms | 10 |
| Lung Neoplasms | 10 |
| Colitis, Ulcerative | 9 |
| Acute-On-Chronic Liver Failure | 9 |
| Crohn Disease | 9 |
| Mouth Neoplasms | 8 |
| Lung Diseases | 8 |
| Recurrence | 8 |
| Periodontitis | 7 |
| Tuberculosis | 7 |
| Biliary Tract Neoplasms | 7 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 50 |
| Institute of Liver and Biliary Sciences, India | 49 |
| Postgraduate Institute of Dental Sciences Rohtak | 42 |
| Tata Memorial Centre | 37 |
| Asian Institute of Gastroenterology, India | 34 |
| Post Graduate Institute of Medical Education and Research, Chandigarh | 29 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 24 |
| All India Institute of Medical Sciences | 22 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 20 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 19 |
| Tata Memorial Hospital | 17 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 16 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 12 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 12 |
| All India Institute of Medical Sciences, Bhubaneswar | 9 |
| University of Pittsburgh | 8 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 7 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 7 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 6 |
| Christian Medical College and Hospital, Ludhiana, India | 5 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 5 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 5 |
| Sir Ganga Ram Hospital | 5 |
| Indira IVF Hospital Pvt Ltd | 5 |
| All India Institute of Medical Sciences, Jodhpur | 4 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Promotional products companies in the United States](https://specstream.ai/data/businesses/promotional-products-companies/united-states)
- [Diagnostic imaging centers in the United States](https://specstream.ai/data/businesses/diagnostic-imaging-centers/united-states)
- [Salvadoran restaurants in the United States](https://specstream.ai/data/businesses/salvadoran-restaurants/united-states)
- [Endocrinology practices in the United States](https://specstream.ai/data/businesses/endocrinology-practices/united-states)
- [Spring suppliers in the United States](https://specstream.ai/data/businesses/spring-suppliers/united-states)
- [Flooring contractors in the United States](https://specstream.ai/data/businesses/flooring-contractors/united-states)
